Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Behavior Therapy × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 5 Hematologic Neoplasms 5 Neoplasms 3 Lung Neoplasms 3 Prostatic Neoplasms 2 Multiple Myeloma 2 Hematopoietic and Lymphatic System Neoplasm 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Weight Cycling 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Substance-Related Disorders 1 Smoldering Multiple Myeloma 1 Smoking Cessation 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Paranasal Sinus Neoplasms 1 Oropharyngeal Neoplasms 1 Obesity-Related Malignant Neoplasm 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Mental Disorders 1 Maxillary Sinus Neoplasms 1 Laryngeal Neoplasms 1 Insulin Resistance 1 Hypopharyngeal Neoplasms 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡